Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010410
Filing Date
2021-08-05
Accepted
2021-08-05 08:16:22
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20210630x10q.htm   iXBRL 10-Q 1233278
2 EX-10.1 glyc-20210630xex10d1.htm EX-10.1 148767
3 EX-31.1 glyc-20210630xex31d1.htm EX-31.1 16945
4 EX-31.2 glyc-20210630xex31d2.htm EX-31.2 16767
5 EX-32.1 glyc-20210630xex32d1.htm EX-32.1 9430
  Complete submission text file 0001558370-21-010410.txt   5244482

Data Files

Seq Description Document Type Size
6 EX-101.SCH glyc-20210630.xsd EX-101.SCH 31332
7 EX-101.CAL glyc-20210630_cal.xml EX-101.CAL 37130
8 EX-101.DEF glyc-20210630_def.xml EX-101.DEF 148473
9 EX-101.LAB glyc-20210630_lab.xml EX-101.LAB 293983
10 EX-101.PRE glyc-20210630_pre.xml EX-101.PRE 278226
11 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20210630x10q_htm.xml XML 862727
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 211146444
SIC: 2834 Pharmaceutical Preparations